Tricuspid atresia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Age) |
(→Age) |
||
| Line 9: | Line 9: | ||
== Age == | == Age == | ||
*[[Tricuspid atresia]] is | *[[Tricuspid atresia]] is a [[congenital heart disease]] observed among infants at the time of birth. | ||
== Gender == | == Gender == | ||
Revision as of 10:14, 21 October 2020
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia epidemiology and demographics |
|
Risk calculators and risk factors for Tricuspid atresia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief:; Sara Zand, M.D.[2] Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Epidemiology and Demographics
Prevalence
- Worldwide, the prevalence of tricuspid atresia is 7.8 per 100,000 persons.[1]
Age
- Tricuspid atresia is a congenital heart disease observed among infants at the time of birth.
Gender
- Tricuspid atresia affects males and females equally.
Race
- There is no racial predilection for tricuspid atresia
References
- ↑ Liu, Yingjuan; Chen, Sen; Zühlke, Liesl; Black, Graeme C; Choy, Mun-kit; Li, Ningxiu; Keavney, Bernard D (2019). "Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies". International Journal of Epidemiology. 48 (2): 455–463. doi:10.1093/ije/dyz009. ISSN 0300-5771.